AR and breast cancer: This improvement in histological and genetic features seems to translate to clinical benefit and AR-positive TNBC have both improved DFS and OS versus AR-negative [110,114,115] One retrospective study analyzing tissue microarrays from 287 patients with operable TNBC breast cancer found a statistically significant decrease in lymph node positivity in AR-positive disease.